Sign in

Acute myeloid leukaemia

Current status: Treatable, not yet curable

A fast-growing cancer of the blood and bone marrow, in which the marrow makes large numbers of abnormal, immature white blood cells. It can cause tiredness, pale skin, shortness of breath, easy bleeding or bruising, and getting ill a lot. Treatment needs to start quickly and is mainly chemotherapy, sometimes with targeted medicines or a stem cell transplant. It can happen at any age, but it is more likely after 60, and the risk keeps rising with age.

Read more about acute myeloid leukaemia
Where research stands todayUpdated 18 Nov 2026

Trial-stage treatments and research studies you can joinOpen trials for referral

Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.

Filters

Country
City
Distance is calculated in your browser. Your city is not sent to us.
Type
Get notified of new trialsUnited Kingdom, all cities, all phases
Your ageShows only trials that take people your age.
Phase
  1. Trial-stage treatmentPhase 1/2Taking people
    Tests ponatinib in children with hard-to-treat leukemias, lymphomas or solid tumors

    Tests ponatinib in children with returning or resistant blood cancers or solid tumors.

    Glasgow, United KingdomAlso Liverpool, SuttonAge 1 to 17
  2. Trial-stage treatmentPhase 3Soon in United Kingdom
    Tests ziftomenib with standard drugs for untreated AML with certain gene changes

    Tests ziftomenib with standard drugs in adults with new AML and certain genes.

    London, United KingdomAge 18+
  3. Trial-stage treatmentPhase 1Taking people
    Testing CHM-029 pill in adults with relapsed or hard-to-treat acute myeloid leukemia

    Tests the new pill CHM-029 in adults with relapsed or hard-to-treat leukemia.

    Manchester, United KingdomAlso Oxford, WalesAge 18+
  4. Trial-stage treatmentPhase 1
    Continued Treatment and Safety Monitoring for People With Certain Cancers

    Follows people with blood cancers and solid tumors who continue study drugs long term.

    Leicester, United KingdomAlso London, PlymouthAge 18+
  5. Trial-stage treatmentPhase 3Taking people
    Tests bleximenib with venetoclax and azacitidine for newly diagnosed acute myeloid leukemia

    Tests bleximenib with venetoclax and azacitidine in adults newly diagnosed with acute myeloid leukemia.

    Brighton, United KingdomAlso Cambridge, Canterbury, Colchester, Edinburgh, Liverpool, London, Plymouth, WorthingAge 18+
  6. Trial-stage treatmentPhase 1Taking people
    AMX-883 for acute myeloid leukaemia and high-risk myelodysplastic syndrome

    Tests AMX-883 alone or with other cancer drugs in adults with these blood cancers.

    Manchester, United KingdomAge 18+
  7. Trial-stage treatmentPhase 3Taking people
    Tests mocravimod with stem cell transplant for acute myeloid leukemia

    Tests mocravimod alongside transplant in adults with acute myeloid leukemia.

    Birmingham, United KingdomAlso Cardiff, Glasgow, London, Manchester, Newcastle upon Tyne, Nottingham, Oxford, SheffieldAge 18 to 75
  8. Trial-stage treatmentPhase 1Taking people
    Tests APL-4098 alone and with other drugs in adults with blood cancers

    Tests APL-4098, alone or with azacitidine, in adults with acute myeloid leukemia or MDS.

    Cardiff, United KingdomAlso Glasgow, LondonAge 18+
  9. Trial-stage treatmentPhase 1/2Taking people
    Tests AZD3632 alone or with other drugs in advanced blood cancers

    Tests the oral drug AZD3632 in adults with advanced leukemia or myelodysplastic syndromes.

    Edinburgh, United KingdomAlso London, Manchester, NewcastleAge 16+
  10. Trial-stage treatmentPhase 3Taking people
    Tests revumenib with chemotherapy for newly diagnosed acute myeloid leukemia with NPM1 mutation

    Tests revumenib added to chemotherapy in people aged 12 and older with newly diagnosed AML.

    Aberdeen, United KingdomAlso Derby, Leicester, Lincoln, London, Oxford, Southampton, SuttonAge 12+
  11. Trial-stage treatmentPhase 2/3Taking people
    Tests oral ASTX030 alone or with venetoclax in myeloid blood cancers

    Tests an oral form of azacitidine, alone or with venetoclax, in adults with blood cancers.

    London, United KingdomAlso Maidstone, Manchester, Oxford, SouthamptonAge 18+
  12. Trial-stage treatmentPhase 1Taking people
    Pivekimab sunirine for children with acute myeloid leukemia that returned or did not respond

    Tests pivekimab sunirine for safety in children with relapsed or refractory acute myeloid leukemia.

    Cambridge, United KingdomAge 0 to 17
  13. Trial-stage treatmentPhase 2Taking people
    Tests bezuclastinib in adults with advanced systemic mastocytosis

    Tests bezuclastinib in adults with advanced systemic mastocytosis, a rare blood disease.

    Leeds, United KingdomAlso LondonAge 18+
  14. Trial-stage treatmentPhase 1/2
    Tests BGB-11417 alone or with azacitidine in myeloid blood cancers

    Tests BGB-11417, alone or with azacitidine, in adults with acute myeloid leukemia or MDS.

    Edinburgh, United KingdomAge 18+
  15. Trial-stage treatmentPhase 3Taking people
    Adding revumenib to standard treatment for newly diagnosed acute myeloid leukemia

    Tests adding revumenib to azacitidine and venetoclax in adults with NPM1 or KMT2A leukemia.

    Belfast, United KingdomAlso Birmingham, Blackpool, Bodelwyddan, Bristol, Cardiff, Cosham, Coventry, Derby, …Age 18+
  16. Trial-stage treatmentPhase 1/2Taking people
    Tests CCS1477 (inobrodib) alone or with other drugs in blood cancers

    Tests CCS1477 (inobrodib) in adults with advanced blood cancers, including leukemia and lymphoma.

    Bebington, United KingdomAlso Bristol, Cardiff, Derby, Edinburgh, Glasgow, Leicester, London, Manchester, …Age 18+
  17. Trial-stage treatmentPhase 1/2Taking people
    Tests experimental drug EP0042 alone and with other cancer treatments

    Tests experimental drug EP0042 in adults with leukemia and related blood cancers.

    London, United KingdomAlso ManchesterAge 18+
  18. Trial-stage treatmentPhase 2Taking people
    Tests two ways to prevent graft-versus-host disease after donor stem cell transplant

    Compares two drug strategies to prevent graft-versus-host disease in people receiving unrelated donor transplants.

    Birmingham, United KingdomAlso Bristol, Cambridge, Cardiff, Glasgow, Leeds, London, Manchester, Newcastle upon Tyne, …Age 16 to 70
  19. Trial-stage treatmentPhase 1/2Taking people
    Tests enzomenib in people with acute leukemia or related blood cancers

    Tests enzomenib, a new drug, in people 12 and older with acute leukemia.

    Birmingham, United KingdomAlso Bristol, Edinburgh, London, Manchester, Oxford, Stoke-on-Trent, SuttonAge 12+
  20. Trial-stage treatmentPhase 1/2Soon in United Kingdom
    Cord blood transplant with extra white blood cells for hard-to-treat leukemia in young adults

    Tests cord blood transplant with granulocyte infusions in adults with very poor risk leukemia.

    London, United KingdomAlso ManchesterAge 16 to 55

Search the publications

The results open on the publications page in a new tab, so this page stays as it is.

Lists with this disease filtered

Where treatment stands

Approved: 34

Officially approved for this disease in the EU, the US, Switzerland or France.

Human testing stage: 32

Being tested in people. Many treatments at this stage are never approved.

Animal testing stage: 5

Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.

Lab research stage: 2

Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.

Support organisations

Patient organisations and helplines in United Kingdom, for you and your family.

Acute myeloid leukaemia organisations in United Kingdom

  • Anthony Nolan - patient services

    Patient helpline for anyone facing a stem cell transplant or CAR-T (Mon-Fri 9am-5pm), telephone emotional support, patient grant, clinical nurse specialists, patients and families forum.

  • Macmillan Cancer Support

    Free cancer support line every day from 8:00 to 20:00, plus chat, an online community and help with money worries.

  • Blood Cancer UK

    Free support line with specialist blood cancer nurses (Mon, Wed-Fri 10am-4pm, Tue 10am-7pm, Sat 10am-1pm; interpreters available), email, online forum, information and clinical-trials help for all blood cancers.

  • Cancer Focus Northern Ireland

    Northern Ireland cancer charity (ECL member) supporting cancer patients, families and carers, funding research and campaigning for better health policies.

  • Cancer Research UK

    UK cancer charity (ECL member) dedicated to cancer research, also providing public cancer information and a nurse helpline.

  • Leukaemia Care

    Free helpline (Mon-Fri 9am-4.30pm) and WhatsApp, buddy support, counselling, advocacy, welfare/benefits advice and small grants, support groups for people with leukaemia, MDS or MPN.

General support in United Kingdom

  • NHS 111

    The NHS's free 24/7 urgent health advice service (phone 111 and NHS 111 online), with the nhs.uk health information website.

  • Samaritans

    UK charity offering free 24/7 confidential emotional support on 116 123 to anyone who is struggling, including people with suicidal thoughts.

  • Public Service Ombudsman (formerly Parliamentary and Health Service Ombudsman)

    Independent ombudsman making final decisions on complaints about the NHS in England and UK government departments not resolved locally.

International organisations

  • DKMS

    Finds blood stem cell donors worldwide so that people with blood cancer can have a transplant.

Frontlight Community

Acute myeloid leukaemia community in United Kingdom

People living with acute myeloid leukaemia and those close to them share what they went through. Posts are not medical advice: ask your doctor about your own treatment.

Offer tissue or data

There are three ways to help research move faster.

Give tissue or bloodA biobank stores your sample so many research teams can use it.See open programmes
Share your health dataA patient registry collects your health data, without your name, for research.How to join
Take part as a healthy volunteerStudies also need people without the disease, for comparison. Family and friends can help.Volunteer

Approved treatments

32 medicines are approved for acute myeloid leukaemia in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.

Checked on 18 Nov 2026 in the official lists of the US (FDA), the EU (European Commission and EMA) and Switzerland (Swissmedic), which we read every day. The lists of Japan (PMDA, approvals since April 2004), France (ANSM, medicines approved in France only) and Taiwan (TFDA) were checked on 11 Nov 2026. For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. The French ratings are the opinions of the HAS Transparency Committee, from the French public medicines database (base de données publique des médicaments, newest opinion 10 Dec 2025). 6 uncertain matches are left out. Other countries' own approvals were not checked.

“Miracle cure” fact checker

Social media spreads misinformation. Paste here what you read, and we'll tell you whether there is scientific evidence behind it.

What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.

Before you pay for anything, ask three things

  1. Is there a published study in people?
  2. Can I have the full price in writing?
  3. What does my doctor say?

About acute myeloid leukaemia

Sources: NHS, NCI PDQ, Cancer Research UK, The New England Journal of Medicine

A fast-growing cancer of the blood and bone marrow, in which the marrow makes large numbers of abnormal, immature white blood cells. It can cause tiredness, pale skin, shortness of breath, easy bleeding or bruising, and getting ill a lot. Treatment needs to start quickly and is mainly chemotherapy, sometimes with targeted medicines or a stem cell transplant. It can happen at any age, but it is more likely after 60, and the risk keeps rising with age.

What is it?

AML is a rare cancer of the blood and bone marrow. Bone marrow, found in the centre of most bones, makes blood cells. In AML it makes large numbers of abnormal, immature white blood cells that crowd out the healthy ones. It is the most common type of acute leukaemia in adults. 'Acute' means it gets worse quickly, so treatment needs to start fast.

It can happen at any age, but it is more likely after 60. Being male may also raise the risk. The risk is also higher if you smoke, had chemotherapy or radiotherapy in the past, have another blood disorder, have a genetic condition such as Down's syndrome, or were often exposed to high levels of the chemical benzene. It is not always clear what causes it.

The first signs

The signs are often not obvious at first and can feel like flu. They usually come on quickly, over a few weeks:

  • feeling very tired or weak;
  • looking paler than usual (on brown or black skin, check the palms or the inside of the eyelids);
  • getting out of breath;
  • bleeding or bruising easily;
  • a high temperature, or getting ill a lot or taking longer than usual to recover from illnesses;
  • aching bones or joints, a swollen tummy or swollen glands.

They can be caused by many other conditions, but they need checking.

How doctors find out

Your family doctor usually arranges an urgent blood test, and may send you to a hospital specialist or straight to hospital. The main tests are blood tests and a bone marrow biopsy: a small sample of marrow is taken with a needle from the hip bone or breastbone, usually after numbing the skin. Gene tests on the leukaemia cells help choose the treatment. You may also need a lumbar puncture (a little fluid taken from the lower back) and scans. Blood results can come within a few days; other tests take a few weeks.

Current treatment

Intensive chemo, sometimes a stem cell transplant

Will it get worse?

Without treatment, AML gets worse quickly, but it is often treatable. How serious it is depends on the type of AML, your age and your general health. In older people, the leukaemia may be less likely to go into remission. Even after remission, the leukaemia can come back, which is why treatment carries on afterwards. When AML cannot be cured, treatment aims to control it, ease symptoms and help you live longer.

Medicines: what helps, and what to watch for

Chemotherapy is the main treatment, usually several medicines together. Intensive treatment aims to cure the leukaemia and is usually given in hospital. Non-intensive treatment aims to control it for as long as possible; it is usually given at home and has fewer side effects. Targeted medicines can be added, for example when the leukaemia has a change in the FLT3 gene. One type, acute promyelocytic leukaemia, may be treated with ATRA and arsenic trioxide.

Good to know:

  • Treatment comes in phases: first to clear the leukaemia from the blood and marrow, then more treatment to kill any cells that are left;
  • AML and chemotherapy lower your blood counts, so you are watched closely and may need blood and platelet transfusions;
  • You may get antibiotics and antifungal medicines to prevent or treat infections;
  • You have regular check-ups, tests and scans during and after treatment;

Exercise and diet help too

Tiredness is one of the most common problems and can continue for months after treatment. After treatment, exercise can help your body and your mood: start gently, for example with walking, and build up slowly. You can go swimming once your white blood cell count is back to normal and you no longer have a central line. A good, balanced diet might help you feel stronger and recover more quickly. Your nurse can refer you to a dietitian or a physiotherapist.

  • After a stem cell transplant, your team may give you food-safety advice for the first few months, such as eating only freshly cooked food;

A transplant, for some people

A stem cell or bone marrow transplant replaces the damaged blood-making cells with healthy ones. First you get high-dose chemotherapy, sometimes with radiotherapy, and then the stem cells are given back to you through an infusion. They can be your own cells or come from a donor. It may be offered if the leukaemia is likely to come back, has come back, or other treatments are not working.

Is there a cure?

Sometimes. Intensive treatment aims to cure AML, and more than 1 in 4 adults live 3 years or more and may be cured. For others, treatment aims to keep it under control. New treatments are being tested in clinical trials.

See the 837 trials you can join

Median survival

About 15 months with azacitidine and venetoclax, for people who cannot have intensive chemotherapy

Measured in: Previously untreated AML in people who could not have intensive chemotherapy (median age 76): the VIALE-A trial (431 patients)

The figures behind it

VIALE-A (431 previously untreated patients who were ineligible for intensive chemotherapy, median age 76): median overall survival 14.7 months with azacitidine plus venetoclax vs 9.6 months with azacitidine alone. People who can have intensive chemotherapy are not part of this figure.